About: Neurological features of COVID-19 and their treatment: a review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neurological features of COVID-19 and their treatment: a review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Neurological features of COVID-19 and their treatment: a review
Creator	Caldarazzo Ienco, Elena Napolitano, Alessandro Nocita, Gianpaolo Orsucci, Daniele Vista, Marco
Source	Medline; PMC; WHO
abstract	Severe acute respiratory syndrome–correlated new coronavirus (SARS-Cov-2) infection may result in neurological signs and symptoms through different mechanisms. Although direct infection of the central nervous system is uncertain or very rare and the para-infectious complications (e.g. inflammatory neuropathies) are rare, delirium and septic encephalopathy are common in severely ill patients. Smell dysfunction and headache are very common in mild cases, especially in younger people and females. Muscle pain is common in both mild and severe cases, and in the most compromised patients, it is accompanied by increased creatine kinase levels and by a likely true myopathic damage. Ischemic stroke has been reported as a possible complication of the hypercoagulability associated with severe SARS-Cov-2 infection, but further studies are needed. Most of the neurological manifestations may occur early in the illness. Therefore, during the pandemic period, neurologists need to be involved, alert, and prepared. Neurological practice will not be the same until a vaccine is available.
has issue date	2020-06-11(xsd:dateTime)
bibo:doi	10.7573/dic.2020-5-1
bibo:pmid	32587625
has license	no-cc
sha1sum (hex)	0a3589362745a48cf5b56f4df61d20224202a3b3
schema:url	https://doi.org/10.7573/dic.2020-5-1
resource representing a document's title	Neurological features of COVID-19 and their treatment: a review
has PubMed Central identifier	PMC7295105
has PubMed identifier	32587625
schema:publication	Drugs Context
resource representing a document's body	covid:0a3589362745a48cf5b56f4df61d20224202a3b3#body_text
is schema:about of	named entity 'Muscle pain' named entity 'neurologists' named entity 'neurological' named entity 'levels' named entity 'mild' named entity 'pandemic' named entity 'delirium' named entity 'inflammatory' named entity 'younger' named entity 'rare' named entity 'signs and symptoms' named entity 'infection' named entity 'Ischemic stroke' named entity 'hypercoagulability' named entity 'myopathic' named entity 'SARS-Cov-2' named entity 'delirium' named entity 'coronavirus' named entity 'peer-reviewed journal' named entity 'open access' named entity 'complication' named entity 'Brescia' named entity 'CNS' named entity 'consciousness' named entity 'neurological disease' named entity 'SARS-Cov-2' named entity 'infection' named entity 'COVID' named entity 'seizures' named entity 'COVID' named entity 'respiratory failure' named entity 'ciliated' named entity 'cerebrovascular disorders' named entity 'ischemic strokes' named entity 'Electroencephalography' named entity 'neurological symptoms' named entity 'Wuhan' named entity 'reverse-transcription polymerase chain reaction' named entity 'diarrhea' named entity 'SARS-Cov-2' named entity 'COVID' named entity 'rhinorrhea' named entity 'neuropathies' named entity 'azithromycin' named entity 'CSF' named entity 'hyperkinetic' named entity 'COVID' named entity 'COVID' named entity 'COVID' named entity 'pyramidal signs' named entity 'lupus anticoagulant' named entity 'low molecular weight heparin' named entity 'New York' named entity 'immunoglobulins' named entity 'intravenous immunoglobulins' named entity 'COVID' named entity 'COVID' named entity 'pacemaker' named entity 'infection' named entity 'CNS' named entity 'locked-in syndrome' named entity 'risk/benefit' named entity 'ARDS' named entity 'electrodiagnostic' named entity 'United States' named entity 'Headache' named entity 'anticoagulation' named entity 'neurological disorders' named entity 'case report' named entity 'macrophages' named entity 'IVIg' named entity 'SARS-Cov-2' named entity 'vessel occlusion' named entity 'serologic test' named entity 'multiple sclerosis' named entity 'ischemic strokes' named entity 'polyneuritis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software